IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

INTEGRA LIFESCIENCES HOLDINGS CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026

$13.45+0.24 (+1.82%)

Close on Oct 19, 2026

Community

Notes and questions about Integra Lifesciences from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Integra Lifesciences's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jan 4, 2017
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IART.

Revenue growth1.6% · median 10.2%

Gross margin52.5% · median 54.9%

Operating margin4.0% · median 11.9%

Net margin-0.4% · median 7.1%

Advertisement
300 × 250